Researchers “Discover” That the Human Immune System Protected Unvaccinated People from COVID19

by
Steve MacDonald

I wish this were a parody. I do. But back in March, an article was published in ‘Interesting Engineering’ titled “A hidden immune feature may have spared unvaccinated people from COVID-19 infections.” It was picked up by the BBC, among others, as if no one had heard of such a thing.

Some human beings appear to have a natural resistance to COVID19 that limits the viral impact and keeps them out of the hospital.

No kidding?

 

For six months, the researchers at the University’s Sahlgrenska Academy investigated 156 employees from five primary care health facilities who were recruited during April and May 2020. None of these employees had been vaccinated against COVID-19, and the majority of them had to work with infected patients on a daily basis during the height of the pandemic.

They identified IgA (immunoglobulin A) in the respiratory tracts of several of the personnel who didn’t catch COVID-19, which could mean they had an antidote in their immune systems all this time.

These antibodies are found naturally in mucous membrane secretions in the airways and gastrointestinal tract, where they protect the body by binding to viruses and other invading organisms.

 

Even children inherently understand the process, if not the actual biology. Their nature drives them to expose themselves to things, and their bodies process that into the human defense system.

Related: Data: COVID Vaccines Cause More COVID Cases per Million and More Deaths per Million

I don’t suppose the “researchers,” or the reporter realized that SARS CoV2 is bits of things most of us have been exposed to all our lives. Something like 80% of it is pre-existing flu strains. As such, our bodies, without any experimental pharmaceutical intervention, can mount an adequate defense against it.

But no one makes money on that.

 

The disease appears to affect some people more severely than others, with some experiencing very minor symptoms and others being hospitalized and requiring aid in breathing. The current study aimed to uncover health factors that appeared to offer COVID-19 protection for the unvaccinated.

 

I should mention that the author of this groundbreaking report (about what sounds to them like life-saving research) states “that the majority of the COVID-19 vaccines are highly effective against severe illness, hospitalization, and death.”

Maybe. For about three to five weeks. After which, the “COVID-19 Vaccines” can make some recipients more susceptible to illness and hospitalization. But let’s not water down this watershed moment. The big news is that people have antibodies, and sometimes they are different, and this affects who gets sick from what.

It is a knowledge we’ve had for … at least a few years.

 

History of the discovery of antibodies

 

 

After being inundated with BS and fearmongering, I suppose a discovery of this amplitude might appear astonishing. New even. But not in any significant way. When push comes to shove, this was never about the flu, and the only antibody for that is free people who refuse to kneel before the self-anointed elite.

Related: Record-Setting Non-Covid Excess Deaths as The Pandemic Politics Piper Has Come to Call

People that reject wearing useless masks. And when can we expect these researchers to make that discovery. Or the one where having them on your face is worse for your health in ways already known?

No rush. Plenty of “research” has been published on how dangerous masking and mass masking is to public health. But how long must we wait before the right sort of researchers discover it and decide that the public needs to know?

 

 

Author

  • Steve MacDonald

    Steve is a long-time New Hampshire resident, blogger, and a member of the Board of directors of The 603 Alliance. He is the owner of Grok Media LLC and the Managing Editor of GraniteGrok.com, a former board member of the Republican Liberty Caucus of New Hampshire, and a past contributor to the Franklin Center for Public Policy.

Share to...